Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Hyperosomolar Therapy for Traumatic Brain-injured Patients Study Protocol for a Multicenter Randomized Open-label Trial With Blinded Adjudication of Primary Outcome

NCT03143751 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT03143751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03143751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Hyperosomolar Therapy for Traumatic Brain-injured Patients Study Protocol for a Multicenter Randomized Open-label Trial With Blinded Adjudication of Primary Outcome
Lead sponsor
Nantes University Hospital
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2017
Completion date
March 5, 2020
Enrollment
370 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe traumatic brain injury